Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 18;11(16):2575.
doi: 10.3390/cells11162575.

Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis

Md Asiful Islam  1   2 , Cinzia Cavestro  3 , Sayeda Sadia Alam  4 , Shoumik Kundu  4 , Mohammad Amjad Kamal  5   6   7   8 , Faruque Reza  9
Affiliations

Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis

Md Asiful Islam et al. Cells. .

Abstract

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) predominantly infects the respiratory system, several investigations have shown the involvement of the central nervous system (CNS) along the course of the illness, with encephalitis being one of the symptoms. The objective of this systematic review was to evaluate the characteristics (clinical, neuro-radiological aspects, and laboratory features) and outcomes of encephalitis in COVID-19 patients. PubMed, Scopus, and Google Scholar databases were searched from 1 December 2019 until 21 July 2022 to identify case reports and case series published on COVID-19 associated with encephalitis. The quality of the included studies was assessed by the Joanna Briggs Institute critical appraisal checklists. This systematic review included 79 studies, including 91 COVID-19 patients (52.7% male) experiencing encephalitis, where 85.6% were adults (49.3 ± 20.2 years), and 14.4% were children (11.2 ± 7.6 years). RT-PCR was used to confirm 92.2% of the COVID-19 patients. Encephalitis-related symptoms were present in 78.0% of COVID-19 patients at the time of diagnosis. In these encephalitis patients, seizure (29.5%), confusion (23.2%), headache (20.5%), disorientation (15.2%), and altered mental status (11.6%) were the most frequently reported neurologic manifestations. Looking at the MRI, EEG, and CSF findings, 77.6%, 75.5%, and 64.1% of the patients represented abnormal results. SARS-CoV-2-associated or -mediated encephalitis were the most common type observed (59.3%), followed by autoimmune encephalitis (18.7%). Among the included patients, 66.7% were discharged (37.8% improved and 28.9% fully recovered), whereas 20.0% of the reported COVID-19-positive encephalitis patients died. Based on the quality assessment, 87.4% of the studies were of high quality. Although in COVID-19, encephalitis is not a typical phenomenon, SARS-CoV-2 seems like a neuropathogen affecting the brain even when there are no signs of respiratory illness, causing a high rate of disability and fatality.

Keywords: COVID-19; SARS-CoV-2; coronavirus; encephalitis; encephalopathy; meningoencephalitis; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram showing the process of selecting eligible studies.
Figure 2
Figure 2
Age distribution of COVID-19 patients with encephalitis.
See this image and copyright information in PMC

References

    1. World Health Organization WHO COVID-19 Dashboard. 2022. [(accessed on 9 August 2022)]. Available online: https://covid19.who.int.
    1. Zhou Z., Kang H., Li S., Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: From neurological manifestations of COVID-19 to potential neurotropic mechanisms. J. Neurol. 2020;267:2179–2184. doi: 10.1007/s00415-020-09929-7. - DOI - PMC - PubMed
    1. Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020;92:552–555. doi: 10.1002/jmv.25728. - DOI - PMC - PubMed
    1. Islam M.A., Kundu S., Alam S.S., Hossan T., Kamal M.A., Hassan R. Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients. PLoS ONE. 2021;16:e0249788. doi: 10.1371/journal.pone.0249788. - DOI - PMC - PubMed
    1. Yusuf F., Fahriani M., Mamada S.S., Frediansyah A., Abubakar A., Maghfirah D., Fajar J.K., Maliga H.A., Ilmawan M., Bin Emran T., et al. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Research. 2021;10:301. doi: 10.12688/f1000research.52216.1. - DOI - PMC - PubMed

Publication types